Diabetic Retinopathy Market to grow at a CAGR of 5.9% reaching USD 11960 Mn by 2029, Market Research

 Diabetic retinopathy is a disorder of the eye that damages the blood vessels of the retina. The retina is the light-sensitive inner surface of the eye on which images are formed. Long-term diabetes affects the retina as high blood glucose levels can damage the tiny blood vessels in the retina. Diabetic retinopathy is broadly classified into non-proliferative diabetic retinopathy and proliferative retinopathy. Treatment for diabetic retinopathy depends on the stage of the disease and is directed toward slowing down or stopping the progression of the disease.

This report aims to provide a comprehensive presentation of the global market for Diabetic Retinopathy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Retinopathy. This report contains market size and forecasts of Diabetic Retinopathy in global, including the following market information:

• Global Diabetic Retinopathy Market Revenue, 2018-2023, 2024-2029, ($ millions)

Report Sample includes:
- Table of Contents
- List of Tables & Figures
- Charts
- Research Methodology

Get FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-diabetic-retinopathy-forecast-2023-2029-560

The global Diabetic Retinopathy market was valued at US$ 7983.2 million in 2022 and is projected to reach US$ 11960 million by 2029, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Laser surgery, injection of corticosteroids or anti-VEGF drugs into the eye, and vitrectomy are some of the available treatments. One feature of diabetic retinopathy is diabetic macular edema. This is a serious medical condition involving leakage of fluid from the minute, delicate, and previously injured blood vessels located at the back of the eye, which then collects in the macula. This results in inflammation of tissue and blurry vision.

We surveyed the Diabetic Retinopathy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment:

Global Diabetic Retinopathy Market, by Type, 2018-2023, 2024-2029 ($ millions)

Global Diabetic Retinopathy Market Segment Percentages, by Type, 2022 (%)

• Laser Surgery
• Injection of Corticosteroids
• Anti-VEGF Drugs
• Vitrectomy

Global Diabetic Retinopathy Market, by Application, 2018-2023, 2024-2029 ($ millions)

Global Diabetic Retinopathy Market Segment Percentages, by Application, 2022 (%)

• Hospitals
• Clinics
• Others

Global Diabetic Retinopathy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)

Global Diabetic Retinopathy Market Segment Percentages, By Region and Country, 2022 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Diabetic Retinopathy revenues in global market, 2018-2023 (estimated), ($ millions)
• Key companies Diabetic Retinopathy revenues share in global market, 2022 (%)

key players include:

• Bayer
• Roche
• Novartis
• TEVA
• Alimera Sciences
• Regeneron Pharmaceuticals
• Boehringer Ingelheim
• Kowa Group
• Ohr Pharmaceutical
• Quark Pharmaceuticals
• Outline of Major Chapters:
• Chapter 1: Introduces the definition of Diabetic Retinopathy, market overview.
• Chapter 2: Global Diabetic Retinopathy market size in revenue.
• Chapter 3: Detailed analysis of Diabetic Retinopathy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Diabetic Retinopathy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: The main points and conclusions of the report.

Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-diabetic-retinopathy-forecast-2023-2029-560

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170
Follow Us On linkedin :- https://www.linkedin.com/company/24-market-reports